Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.41 |
| ▸ | NOS2 | P35228 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PDXK | O00764 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.34 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.34 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13176938 | 0.85 | KDM4E (0.58) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL20118855 | 0.82 | KDM4E (0.34) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL17545521 | 0.81 | NOS3 (0.43) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL12319209 | 0.79 | NOS3 (0.38) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL13498731 | 0.78 | KDM4E (0.60) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL21279618 | 0.76 | KDM4E (0.38) | NOS3NOS2KDM4EALDH1A1HPGD | |
| SCHEMBL28177564 | 0.72 | NOS3 (0.38) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL3802342 | 0.72 | HPGD (0.53) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL3793200 | 0.72 | ALDH1A1 (0.36) | NOS3NOS2NOS1KDM4EALDH1A1 | |
| SCHEMBL16418384 | 0.71 | KDM4E (0.52) | NOS3NOS2NOS1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2964224-B1 | POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT | POLYACTIVA PTY LTD (AU) | 2024-07-03 | — | — | EP | disclosed |
| WO-2021051149-A1 | BIODEGRADABLE DRUG-POLYMER CONJUGATE | POLYACTIVA PTY LTD (AU) | 2021-03-25 | — | — | WO | disclosed |
| EP-2863921-B1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2018-04-18 | — | — | EP | disclosed |
| WO-2018050938-A1 | PRE-LOADED INJECTABLE DEVICE FOR TREATING CEREBRAL EDEMA | SERVICIO ANDALUZ DE SALUD (ES) | 2018-03-22 | — | — | WO | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-20170216308-A1 | POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT | POLYACTIVA PTY LTD (AU) | 2017-08-03 | — | — | US | disclosed |
| US-9572892-B2 | Polymer conjugate for delivery of a bioactive agent | POLYACTIVA PTY LTD (AU) | 2017-02-21 | — | — | US | disclosed |
| EP-1438352-B1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | CYTEC TECH CORP (US) | 2010-05-26 | — | — | EP | disclosed |
| EP-1438352-A1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | Cytec Technology Corp. (US) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003035735-A1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2003-05-01 | — | — | WO | disclosed |
| US-4095992-A | Coatings containing starch esters | THE SHERWIN-WILLIAMS COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4061610-A | Coating compositions containing starch half-esters and process for preparing same | THE SHERWIN-WILLIAMS COMPANY (US) | 1977-12-06 | — | — | US | disclosed |
| US-4011392-A | COATINGS | THE SHERWIN-WILLIAMS COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3989698-A | ACYLATION, TERTIARY AMINE CATALYST, ISATOIC ANHYDRIDE | THE SHERWIN-WILLIAMS COMPANY (US) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170216308-A1 | POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT | PTGIS, PTGIR, PGF | NOS3 149/4885NOS2 229/4885NOS1 307/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | NOS3 3552/4885NOS2 2483/4885NOS1 1726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.